Attorney blasts Grassley's CME probe

Share this article:
There's “a certain amount of hypocrisy” in Sen. Chuck Grassley's current probe of drug company involvement in CME programs, writes industry attorney Jeffrey N. Gibbs (Hyman, Phelps & McNamara) in a Washington Legal Foundation legal backgrounder.

The Iowa Republican's Senate Finance Committee, composed of lawmakers who, like most 
others on Capitol Hill, receive money from lobbyists, “seem concerned that [CME] speakers might be influenced by a purely internal function performed by [drug company] marketing staff,” Gibbs writes. 
He cites a Jan. 9 Grassley letter to drug companies that stated “[I]t appears that many manufacturers' sales and/or marketing personnel still have a role in originating or evaluating grant requests, and, consequently, the potential for abuse remains.” 

The letter's assertion “makes little or no sense,” Gibbs said. “Sponsors routinely review proposals for CME support from a variety of perspectives. … It is unrealistic to expect companies to expend significant sums on programs which may be educationally worthwhile but bear no relationship…to the company's business objectives. 

“More important,” Gibbs said, “the participation of marketing personnel in a proposal in no way diminishes the independence of the program.”
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"